NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms

. Agreement initiates process for future acquisition of Lonza sites in Ploermel (FR) and Edinburgh (UK) allowing NextPharma to broaden technology offering into lipid finished dosage forms Centers of excellence employing a total of 390 staff offer expertise in Lipid Oral Dosage Forms including softgels and liquid-filled hard capsules for the pharma and nutrition markets Read more about NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms[…]